TipRanks
Delorean Corporation Ltd (AU:DEL)
ASX:DEL
Australian Market
Want to see AU:DEL full AI Analyst Report?

Delorean Corporation Ltd (DEL) AI Stock Analysis

20 Followers

Top Page

AU:DEL

Delorean Corporation Ltd

(Sydney:DEL)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - Gpt-5.6Sol)
Rating:41Neutral
Price Target:
AU$0.08
â–¼(-19.00% Downside)
Action:Reiterated
Date:10/29/26
The score is held down primarily by weak financial performance: sharp revenue contraction, continued negative margins, significant cash burn (deeply negative free cash flow), and a materially riskier balance sheet with rapidly rising debt and very high leverage. Technicals add further pressure with the stock trading below key moving averages and sub-neutral RSI. Valuation provides limited support due to negative earnings (negative P/E) and no dividend yield data.
Positive Factors
Biogas Infrastructure Focus
The company operates in renewable infrastructure tied to biogas capture, energy generation and emissions reduction. This positions Delorean in a structural transition toward recovering value from organic waste while producing renewable electricity and environmental benefits.
Negative Factors
Revenue Contraction
Two consecutive years of declining revenue indicate that the company has not yet established a durable growth trajectory. Prolonged contraction can reduce operating leverage, weaken project funding capacity, and make it harder to rebuild sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Biogas Infrastructure Focus
The company operates in renewable infrastructure tied to biogas capture, energy generation and emissions reduction. This positions Delorean in a structural transition toward recovering value from organic waste while producing renewable electricity and environmental benefits.
Read all positive factors

Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)

Delorean Corporation Ltd Business Overview & Revenue Model

Company Description
Delorean Corporation Limited is an Australian enterprise deeply involved in the renewable energy and waste management industries across both Australia and New Zealand. Its comprehensive business model is segmented into Infrastructure, Engineering,...
How the Company Makes Money
Delorean Corporation’s revenue model is based on monetising biogas and the energy and environmental attributes derived from it. Key revenue streams include: (1) electricity generation revenue from converting captured biogas into power and selling ...

Delorean Corporation Ltd Financial Statement Overview

Summary
Financial fundamentals are weak across all statements: revenue declined sharply (~40% in FY2026 after a FY2025 drop), profitability remains negative with deeply negative operating margins, and cash flow is a major concern with consistently negative operating cash flow and deeply negative free cash flow (including ~-22.8M in FY2026). Balance sheet risk has risen materially as debt increased to ~49.9M in FY2026 and leverage is very elevated (debt-to-equity ~6.6x).
Income Statement
22
Negative
Balance Sheet
28
Negative
Cash Flow
16
Very Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue8.54M19.83M27.88M19.25M39.33M
Gross Profit-3.25M-2.99M7.83M-7.18M-6.77M
EBITDA-4.03M-6.13M5.04M-9.06M-11.87M
Net Income-916.03K-6.55M4.77M-10.02M-10.89M
Balance Sheet
Total Assets63.97M48.30M28.05M17.92M24.10M
Cash, Cash Equivalents and Short-Term Investments5.41M10.66M8.84M1.00M3.12M
Total Debt49.89M31.31M9.07M7.62M2.63M
Total Liabilities55.66M40.45M19.28M15.75M12.21M
Stockholders Equity8.31M7.85M8.77M2.17M11.88M
Cash Flow
Free Cash Flow-22.83M-21.50M6.89M-6.80M-15.21M
Operating Cash Flow-1.69M-5.66M7.24M-5.36M-11.77M
Investing Cash Flow-19.34M-15.08M-3.92M-1.44M-3.44M
Financing Cash Flow17.29M23.33M915.22K4.68M5.26M

Delorean Corporation Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.10
Price Trends
50DMA
0.09
Negative
100DMA
0.09
Negative
200DMA
0.09
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
40.42
Neutral
STOCH
-3.30
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DEL, the sentiment is Negative. The current price of 0.1 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and above the 200-day MA of 0.09, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 40.42 is Neutral, neither overbought nor oversold. The STOCH value of -3.30 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DEL.

Delorean Corporation Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$17.65B18.105.60%3.62%6.62%11.55%
58
Neutral
AU$17.12M9.4612.83%―57.73%30.59%
49
Neutral
AU$38.90M2.3665.86%―――
44
Neutral
AU$90.64M-6.35-718.72%―27.74%49.26%
43
Neutral
AU$61.96M-20.71-14.42%―42.98%-9.38%
42
Neutral
AU$20.97M-1.85-138.53%――-29.75%
41
Neutral
AU$21.51M-20.73-15.03%―-52.16%96.81%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DEL
Delorean Corporation Ltd
0.09
-0.06
-39.29%
AU:CCE
Carnegie Clean Energy Ltd
0.15
0.07
95.95%
AU:JNS
ReNu Energy Limited
0.48
0.31
182.35%
AU:KPO
Kalina Power Limited
0.01
>-0.01
-35.00%
AU:14D
1414 Degrees Ltd.
0.03
>-0.01
-6.45%
AU:VPR
Volt Power Group Ltd
0.11
-0.05
-30.00%

Delorean Corporation Ltd Corporate Events

Delorean sets November date for 2026 AGM and streamlines proxy voting
Oct 27, 2026
Delorean Corporation Ltd has scheduled its 2026 Annual General Meeting of shareholders to be held in person at its West Perth premises on 27 November 2026 at 9:00am AWST. Shareholders are directed to access the Notice of Meeting, Explanatory Memor...
Delorean Calls 2026 AGM, Seeks Director Re-Elections and Share Placement Ratification
Oct 27, 2026
Delorean Corporation Ltd has called its annual general meeting for 27 November 2026 in West Perth, setting 25 November 2026 as the record date for shareholder voting. The meeting will review the financial report for the year ended 30 June 2026, in...
Delorean Wins Licence for Pioneering SA1 Bioenergy Plant
Oct 19, 2026
Delorean Corporation Ltd has secured a key regulatory milestone for its 100% owned SA1 Salisbury Bioenergy Project in South Australia, with the South Australian Environment Protection Authority issuing an operational licence. The facility, about 9...
Delorean secures Westpac mandate to fund NSW Horsley Park bioenergy project
Oct 12, 2026
Delorean Corporation has entered into a non-binding financing agreement and mandate with Westpac Banking Corporation for $20 million to fund capital plant and equipment for its NSW1 Horsley Park Bioenergy Project in Western Sydney. The project, co...
Delorean Corporation Updates Market on Director’s Expired Performance Shares
Oct 9, 2026
Delorean Corporation Ltd, an Australian listed company, holds its equity interests through family and superannuation structures associated with director Hamish Jolly, including Dunbar-Harper Pty Ltd and Antediluvian Pty Ltd. The company’s ca...
Delorean Corporation Cuts Dilution as Over 9 Million Performance Rights Expire
Oct 9, 2026
Delorean Corporation Ltd has notified the market of the cessation of a large tranche of performance rights on its register. The company reported that 9,114,476 DELAA performance rights have lapsed, following expiry without being exercised or conve...
Delorean Sets Date and Director Nomination Deadline for 2026 AGM
Oct 6, 2026
Delorean Corporation Ltd has scheduled its 2026 Annual General Meeting for 9:00 a.m. AWST on Friday, 27 November 2026, in Perth, and has set 13 October 2026 as the closing date for director nomination submissions. The company will provide further ...
Delorean Corporation Lodges Appendix 4G, Confirms Governance Compliance
Sep 30, 2026
Delorean Corporation Ltd has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 30 June 2026 is available on its website. The statement, approved by the board as at 30 September 2026, outlines complianc...
Delorean Details 2026 Corporate Governance Framework and Board Oversight
Sep 30, 2026
Delorean Corporation Ltd has detailed its 2026 corporate governance practices, reaffirming a commitment to high standards under the ASX Corporate Governance Principles. The Board’s charter defines responsibilities spanning long-term strategy...
Delorean Targets Emerging Market for Renewable Natural Gas in Australia
Sep 30, 2026
Delorean Corporation Ltd operates in Australia’s renewable energy sector, focusing on bioenergy and renewable natural gas. The company is building infrastructure and partnerships to supply lower-carbon gas solutions, targeting hard-to-abate ...
Delorean and Opal Advance $35m Bioenergy Project at Maryvale Mill
Sep 22, 2026
Delorean Corporation and Paper Australia’s Opal have completed the Concept Stage of their collaboration to develop a bioenergy facility at Opal’s Maryvale Mill in Victoria, advancing plans to convert organic residues and paper by-produ...
Delorean advances BOO renewable gas strategy as losses narrow and assets grow
Aug 31, 2026
Delorean reported FY26 revenue of $8.5 million, down 56% from FY25, but delivered a positive EBITDA of $0.18 million and cut its total comprehensive loss after tax to $0.9 million, an 86% improvement. Total assets rose to $63 million and cash and ...
Delorean boosts funding as key renewable gas projects advance toward delivery
Jul 31, 2026
Delorean Corporation reported a cash balance of $5.6 million at 30 June 2026, supported by $1.06 million in customer receipts and a $5.76 million RD tax refund that underpins ongoing bioenergy infrastructure development. The company also completed...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2026